Literature DB >> 10385447

Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from disease.

C D Sturgis1, N P Caraway, D A Johnston, S I Sherman, L Kidd, R L Katz.   

Abstract

BACKGROUND: Papillary thyroid carcinoma is the most common thyroid malignancy in the U.S. As many as half of patients with papillary carcinoma present with cervical lymph node metastases at the time of diagnosis. Metastatic disease involving cervical lymph node tissue has not historically been proven to correlate with a more aggressive course; however, distant metastases worsen prognosis.
METHODS: Diagnostic fine-needle aspiration (FNA) smears from 26 primary and metastatic papillary carcinomas underwent Feulgen reaction and were studied by image analysis to determine DNA pattern, proliferation index, and the percentage of cells with DNA content >5C. The medical records of all the patients were reviewed for metastatic disease pattern and survival data. For metastatic pattern, two groups were defined: 1) confined to thyroid/local lymph node metastases/soft tissues of the neck involved by tumor, and 2) distant metastases.
RESULTS: Among the 26 patients, 16 had "nonaggressive" DNA patterns described as diploid, abnormal diploid, or tetraploid, and 10 had "aggressive" DNA patterns described as aneuploid. Only 2 of the 16 patients in the "nonaggressive" DNA pattern group developed distant metastases, whereas 5 of the 10 patients in the aneuploid group developed distant metastatic disease. In addition, none of the 16 patients with "nonaggressive" DNA patterns died of disease, whereas 3 of the 10 individuals with DNA histograms interpreted as aneuploid did die of metastatic disease complications.
CONCLUSIONS: Aneuploidy identified by image analysis of FNA of papillary thyroid carcinoma is significantly associated with death from papillary carcinoma (log rank test, P=0.027).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385447     DOI: 10.1002/(sici)1097-0142(19990625)87:3<155::aid-cncr9>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  A benchmark for comparing precision medicine methods in thyroid cancer diagnosis using tissue microarrays.

Authors:  Ching-Wei Wang; Yu-Ching Lee; Evelyne Calista; Fan Zhou; Hongtu Zhu; Ryohei Suzuki; Daisuke Komura; Shumpei Ishikawa; Shih-Ping Cheng
Journal:  Bioinformatics       Date:  2018-05-15       Impact factor: 6.937

Review 2.  Aurora kinase inhibitors--rising stars in cancer therapeutics?

Authors:  Altaf A Dar; Laura W Goff; Shahana Majid; Jordan Berlin; Wael El-Rifai
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

3.  Three-dimensional telomere dynamics in follicular thyroid cancer.

Authors:  Landon Wark; Adrian Danescu; Suchitra Natarajan; Xuguang Zhu; Sheue-yann Cheng; Sabine Hombach-Klonisch; Sabine Mai; Thomas Klonisch
Journal:  Thyroid       Date:  2013-09-04       Impact factor: 6.568

Review 4.  The pituitary tumor transforming gene in thyroid cancer.

Authors:  G D Lewy; N Sharma; R I Seed; V E Smith; K Boelaert; C J McCabe
Journal:  J Endocrinol Invest       Date:  2012-04-05       Impact factor: 4.256

5.  Cytologic features, immunocytochemical findings, and DNA ploidy in four rare cases of epithelioid hemangioendothelioma involving effusions.

Authors:  Ying Chen; Abha Khanna; Jie Qing Chen; Hua Zhong Zhang; Nancy P Caraway; Ruth L Katz
Journal:  Cytojournal       Date:  2018-05-22       Impact factor: 2.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.